Clinical Trial Update: Early Response-adapted Intensification of Induction Chemotherapy in Patients With Newly Diagnosed Multiple Myeloma (MM) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating early response-adapted intensification of induction chemotherapy in newly diagnosed multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Chonnam National University Hospital | Conditions: Multiple Myeloma | Phase 2 | Status: UNKNOWN